Iterative Scopes
Iterative Scopes: Enhancing colon cancer prevention with machine learning diagnostic tools.
Founded
2017Iterative Scopes: Enhancing colon cancer prevention with machine learning diagnostic tools.
Founded with the mission to revolutionize gastroenterology, Iterative Scopes leverages machine learning to develop diagnostic tools aimed at preventing colon cancer and enhancing patient outcomes. The company focuses on providing gastroenterologists with advanced computer-aided detection (CADe) devices that improve the accuracy and efficiency of adenoma detection during colonoscopies. By integrating cutting-edge technology into routine medical procedures, Iterative Scopes aims to significantly reduce the incidence of colorectal cancer.
Notable figures associated with Iterative Scopes include leading researchers and healthcare professionals in the field of gastroenterology. The company has garnered attention and support from prominent investors and has presented award-winning research at major conferences such as the American Journal of Gastroenterology. Iterative Scopes' innovative approach has already made a significant impact, demonstrating improved adenoma detection rates and contributing to better patient care and outcomes in gastroenterology.
Companies similar to Iterative Scopes include Quantitative Insights, Crosscope, Ahead Project and Owl Peak Technologies.
Iterative Scopes was founded in 2017.
Iterative Scopes' headquarters is located in Cambridge, MA, US.
Iterative Scopes' most recent funding round was for $150M (USD) in January 2022.
As of Jan 19, 2022, Iterative Scopes has disclosed funding of $195.6M (USD). Undisclosed round amounts are excluded.
Iterative Scopes has 175 employees as of Feb 5, 2024.
Owl Peak Technologies
